RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ: RAPP · HEALTHCARE · BIOTECHNOLOGY
$33.00
-2.19% today
Updated 2026-04-29
Market cap
$1.58B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$8 – $42
Volume
0.3M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$53.60
+62.42%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-24.87M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-10.65M | $-34.79M | $-78.31M | $-111.48M | $-33.76M |
| EPS | — | — | — | — | $-2.86 |
| Free cash flow | $-3.53M | $-28.82M | $-67.23M | $-88.09M | $-24.87M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Rapport Therapeutics, Inc. Common Stock trades at $33.00. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Rapport Therapeutics, Inc. Common Stock's stock price?
Rapport Therapeutics, Inc. Common Stock (RAPP) trades at $33.00.
Is Rapport Therapeutics, Inc. Common Stock overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Rapport Therapeutics, Inc. Common Stock (RAPP)?
The analyst target price is $53.60, representing +62.4% upside from the current price of $33.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-28.20%
Beta—
50D MA$31.45
200D MA$26.08
Shares out0.05B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—